Historical record - last NADAC effective date: 3/17/2021
Product Information
ARIPIPRAZOLE 30 MG TABLET is a generic product labeled by Ascend Laboratories, LLC, priced at $0.3149 per EA under NDC 67877043501. Its NADAC has been published 66 times since Jan 1, 2020.
FDA first approved this application on Feb 21, 2019. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
30 mg/1
Manufacturer
Ascend Laboratories, LLCNDC
67877043501
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
3/17/2021
Active Ingredients
ARIPIPRAZOLEApproval Type
Generic (ANDA)
FDA Application
ANDA207105FDA Approved
2/21/2019
TE Code
AB
On Market Since
2/27/2019
Pharmacological Classes
Price Statistics
The NADAC for ARIPIPRAZOLE 30 MG TABLET has been published 66 times since Jan 1, 2020, and over the history we have for it it has declined 25.2%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.3149 per EA |
|---|---|
| All-time high | $0.4586 (Apr 15, 2020) |
| All-time low | $0.2766 (Feb 17, 2021) |
| Median price | $0.3459 |
| Average price | $0.3576 |
| Largest weekly change | -18.9% (Aug 19, 2020) |
| Weeks tracked | 66 |
| Tracking since | Jan 1, 2020 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
N/A
3Y
N/A
5Y
N/A
All
-25.2%
Last surveyed Mar 31, 2021 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 14 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 48% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of ARIPIPRAZOLE 30 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for ARIPIPRAZOLE 30 MG TABLET, manufactured by Ascend Laboratories, LLC, is $0.3149 per EA (NDC 67877043501), effective Mar 31, 2021.
How has the price of ARIPIPRAZOLE 30 MG TABLET changed over time?
Over the history we have for it, the NADAC for ARIPIPRAZOLE 30 MG TABLET has declined 25.2%. It has been tracked across 66 weekly CMS publications since Jan 1, 2020.
What are the highest and lowest recorded NADAC prices for ARIPIPRAZOLE 30 MG TABLET?
Since Jan 1, 2020, the NADAC for ARIPIPRAZOLE 30 MG TABLET has ranged from a low of $0.2766 (Feb 17, 2021) to a high of $0.4586 (Apr 15, 2020), with a median of $0.3459 per EA.
Are there cheaper alternatives to ARIPIPRAZOLE 30 MG TABLET?
Yes. 14 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, ARIPIPRAZOLE 30 MG TABLET, is $0.1646 per EA — about 48% below ARIPIPRAZOLE 30 MG TABLET.
Who manufactures ARIPIPRAZOLE 30 MG TABLET?
ARIPIPRAZOLE 30 MG TABLET (NDC 67877043501) is labeled by Ascend Laboratories, LLC, and CMS classifies it as a generic product.